NEOGENOMICS INC — Director's Dealing 2026

Jan 5, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2026-01-01

Reporting Person: Kenny John P. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-01	Stock Option (Right to Buy)	$11.76	A	4171	Acquired	2036-01-01	Common Stock (4171)	Direct
2026-01-01	Restricted Stock Unit	$0	A	5893	Acquired		Common Stock (5893)	Direct

Footnotes

F1: Once vested, the shares of common stock are not subject to expiration.